Severe phenotype of Morquio A disease in a child with S287L N-acetylgalactosamine-6-sulfate sulfatase mutation

被引:0
|
作者
Gucev, Zoran S. [1 ]
Bouzidi, Hassan [2 ]
Tasic, Velibor [1 ]
Popjordanova, Nada [1 ]
Kirovski, Ilija [1 ]
Trajkovski, Zoran [2 ]
Jancevska, Aleksandra [1 ]
Bajrami, Sami [1 ]
机构
[1] Univ Hosp Sick Children, Sch Med, Skopje 1000, Fyrom, Macedonia
[2] Tahar Sfar Hosp, Biochem Lab, Mahdia 5100, Tunisia
来源
关键词
Morquio A disease; N-acetyl galactosamine-6-sulphate sulfatase; S287L mutation; severe phenotype;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mucopolysaccharidosis IVA is caused by a deficiency of lysosomal N-acetyl-galactosamine-6-sulfate sulfatase (GALNS; E.C.3.1.6.4). One hundred fourty-eight GALNS mutations were described in patients with different phenotype severity. Our patient was a 6.5 year old boy with severe kyphoscoliosis and growth delay. He developed coarsening of the facial features and megalencephaly. Both corneas were cloudy. His gait was difficult with limited and painful movements in the hips, the spine and the knees. X-ray studies showed platispondily with ovoid vertebrae, bulging sternum and flaring of the rib cage. The long bones were short with irregular trabeculation. Metaphyses were widened, femoral head was flattened. The metacarpals had conical bases. Total excretion of glycosaminoglycans (GAG) in urine was increased. Thin layer chromatography of urinary GAG showed massive excretion of keratan sulphate. N-acetyl Galactosamine-6-sulphate sulfatase activity in leukocytes was low (0.7 nmol/MU17h/mg protein). DNA sequencing detected a S287L, mutation (c.860C>Tc.860 C>T). This is the first GALNS mutation described in our population. The same mutation conferred a severe NIPS IVA phenotype in a American, Austrian and Polish patients.
引用
收藏
页码:383 / 386
页数:4
相关论文
共 50 条
  • [41] Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris
    Alexander Rodríguez-López
    Carlos J. Alméciga-Díaz
    Jhonnathan Sánchez
    Jefferson Moreno
    Laura Beltran
    Dennis Díaz
    Andrea Pardo
    Aura María Ramírez
    Angela J. Espejo-Mojica
    Luisa Pimentel
    Luis A. Barrera
    Scientific Reports, 6
  • [42] Human recombinant N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in a glycoengineered Escherichia coli strain
    Almeciga-Diaz, Carlos J.
    Pimentel-Vera, Luisa N.
    Rodriguez-Lopez, Alexander
    Espejo-Mojica, Angela
    Ramirez, Aura M.
    Cardona, Carolina
    Reyes, Luis H.
    DeLisa, Matthew P.
    Sanchez, Oscar F.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S20 - S20
  • [43] Mucopolysaccharidosis IVA: Four new exonic mutations in patients with N-acetylgalactosamine-6-sulfate sulfatase deficiency
    Tomatsu, S
    Fukuda, S
    Yamagishi, A
    Cooper, A
    Wraith, JE
    Hori, T
    Kato, Z
    Yamada, N
    Isogai, K
    Kondo, N
    Suzuki, Y
    Shimozawa, N
    Orii, T
    AMERICAN JOURNAL OF HUMAN GENETICS, 1996, 58 (05) : 950 - 962
  • [44] Recombinant human N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in the methylotrophic yeast Pichia pastoris
    Rodriguez-Lopez, Alexander
    Almeciga-Diaz, Carlos J.
    Sanchez, Jhonnathan
    Moreno, Jefferson
    Beltran, Laura
    Diaz, Dennis
    Pardo, Andrea
    Maria Ramirez, Aura
    Espejo-Mojica, Angela J.
    Pimentel, Luisa
    Barrera, Luis A.
    SCIENTIFIC REPORTS, 2016, 6
  • [45] Process Development for the GMP Production of N-Acetylgalactosamine-6-Sulfate Sulfatase (GALNS) Expressed by CHO Cells
    Fux, Cornelia
    Bellon, Christele
    Heinzen, Christoph
    CELLS AND CULTURE, 2010, 4 : 275 - 279
  • [46] Cell uptake evaluation of human recombinant N-acetylgalactosamine-6-sulfate sulfatase (GALNS) produced in Pichia pastoris
    Rodriguez-Lopez, Alexander
    Cardona, Carolina
    Pimentel, Natalia
    Espejo-Mojica, Angela J.
    Almeciga-Diaz, Carlos J.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S116 - S116
  • [47] Investigation of Pharmacological Chaperones and Gluthathione in the Enhancement of N-Acetylgalactosamine-6-Sulfate Sulfatase (GALNS) in the Treatment of Mucopolysaccharidosis IVA
    Walter, Patrick
    Otto, Shane
    Sharf, Kyle
    Riddett, Elizabeth
    Tan, Hsein Huey
    Fournier, Roxanne
    Zhang, Fuming
    Choy, Francis
    Linhardt, Robert
    Lum, Julian
    Harmatz, Paul
    FREE RADICAL BIOLOGY AND MEDICINE, 2014, 76 : S95 - S96
  • [48] MOLECULAR ANALYSIS BY SOUTHERN BLOT FOR THE N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE GENE CAUSING MUCOPOLYSACCHARIDOSIS IVA IN THE JAPANESE POPULATION
    TOMATSU, S
    FUKUDA, S
    UCHIYAMA, A
    HORI, T
    NAKASHIMA, Y
    KONDO, N
    SUZUKI, Y
    SHIMOZAWA, N
    SUKEGAWA, K
    ORII, T
    JOURNAL OF INHERITED METABOLIC DISEASE, 1994, 17 (05) : 601 - 605
  • [49] Common N-acetylgalactosamine-6-sulfate sulfatase (GALNS) exon mutations in Brazilian patients with mucopolysaccharidosis IVA (MPS IVA)
    Dieter, Tatiana
    Matte, Ursula da Silveira
    Schwartz, Ida Vanessa
    Tornatsu, Shunji
    Giugliani, Roberto
    GENETICS AND MOLECULAR BIOLOGY, 2007, 30 (03) : 524 - 528
  • [50] Production and characterization of a recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in E. coli BL21
    Almeciga-Diaz, Carlos
    Mosquera, Angela
    Reyes, Felice
    Soto, Carlos
    Rodriguez, Alexander
    Lizaraso, Lina
    Espejo, Angela
    Sanchez, Oscar
    Barrera, Luis
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S5 - S5